Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the ELSS median (51 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Feb 2025 – 20 Aug 2026, limited by Bajaj Finserv ELSS Tax Saver Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Bajaj Finserv ELSS Tax Saver Fund | Nifty 500 |
|---|---|---|
| 03 Feb 2025 | ₹100.00 | ₹100.00 |
| 22 Mar 2025 | ₹103.99 | ₹99.40 |
| 08 May 2025 | ₹106.59 | ₹102.06 |
| 24 Jun 2025 | ₹111.50 | ₹107.99 |
| 10 Aug 2025 | ₹107.60 | ₹104.86 |
| 26 Sep 2025 | ₹109.17 | ₹106.12 |
| 12 Nov 2025 | ₹114.84 | ₹111.37 |
| 28 Dec 2025 | ₹113.63 | ₹111.11 |
| 13 Feb 2026 | ₹111.92 | ₹108.93 |
| 01 Apr 2026 | ₹101.59 | ₹97.82 |
| 18 May 2026 | ₹111.35 | ₹104.95 |
| 04 Jul 2026 | ₹116.02 | ₹108.87 |
| 20 Aug 2026 | ₹116.52 | ₹109.86 |
| Metric | Bajaj Finserv · Regular NAV ₹11.69 Very High risk ★★★☆☆ 1Y | Category median ELSS · 51 funds |
|---|---|---|
| +5.22% | +2.06% | |
| — | +13.00% | |
| — | +12.22% | |
| — | +12.69% | |
| +10.43% | +13.09% | |
| +7.35% | — | |
| — | +14.73% | |
| — | +15.15% | |
| — | +14.10% | |
| Risk | ||
| 13.20% | 14.18% | |
| -0.10 | 0.47 | |
| -0.14 | 0.63 | |
| -14.08% | -37.97% | |
| Nifty 500 | — | |
| — | +0.84% | |
| — | 0.97 | |
| — | 100.1% | |
| — | 95.6% | |
| 2.99% | 1.93% | |
| ₹82.41Cr | ₹857.48Cr | |
| None | — | |
| 3 years | — | |
| ₹500 | — | |
| ₹500 | — | |
| 138% | 33% | |
| Siddharth Chaudhary | — | |
| 03 Feb 2025 | — | |
| 49 | — | |
| 43.1% | — | |
| 1.9% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.